Correlation Between Neogen and Aclaris Therapeutics
Can any of the company-specific risk be diversified away by investing in both Neogen and Aclaris Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neogen and Aclaris Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neogen and Aclaris Therapeutics, you can compare the effects of market volatilities on Neogen and Aclaris Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neogen with a short position of Aclaris Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neogen and Aclaris Therapeutics.
Diversification Opportunities for Neogen and Aclaris Therapeutics
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Neogen and Aclaris is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Neogen and Aclaris Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aclaris Therapeutics and Neogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neogen are associated (or correlated) with Aclaris Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aclaris Therapeutics has no effect on the direction of Neogen i.e., Neogen and Aclaris Therapeutics go up and down completely randomly.
Pair Corralation between Neogen and Aclaris Therapeutics
Given the investment horizon of 90 days Neogen is expected to under-perform the Aclaris Therapeutics. In addition to that, Neogen is 1.38 times more volatile than Aclaris Therapeutics. It trades about -0.06 of its total potential returns per unit of risk. Aclaris Therapeutics is currently generating about 0.01 per unit of volatility. If you would invest 248.00 in Aclaris Therapeutics on November 3, 2024 and sell it today you would earn a total of 0.00 from holding Aclaris Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neogen vs. Aclaris Therapeutics
Performance |
| Timeline |
| Neogen |
| Aclaris Therapeutics |
Neogen and Aclaris Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neogen and Aclaris Therapeutics
The main advantage of trading using opposite Neogen and Aclaris Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neogen position performs unexpectedly, Aclaris Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclaris Therapeutics will offset losses from the drop in Aclaris Therapeutics' long position.| Neogen vs. Qiagen NV | Neogen vs. Aclaris Therapeutics | Neogen vs. IQVIA Holdings | Neogen vs. Medpace Holdings |
| Aclaris Therapeutics vs. Neogen | Aclaris Therapeutics vs. Qiagen NV | Aclaris Therapeutics vs. Sotera Health Co | Aclaris Therapeutics vs. RadNet Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |